Decompensation Detection Study | Clinical Trial

Key information

Conditions

Heart Failure Cardiovascular Diseases Heart Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients implanted with an approved Guidant CRT-D HF device programmed to CRT therapy in VDD or DDD mode.
Patients prescribed to the LATITUDE(R) system configured for at least weekly device interrogations and symptoms reporting.
Patients willing to use the LATITUDE(R) enabled weight scale.

Exclusion criteria

Patients that require adaptive rate pacing (rate-responsive modes).
Patients that have received routinely scheduled intravenous inotropic therapy as part of their drug regimen within the past 90 days.
Both

Treatment and study plan

Primary outcomes

Data collection and analysis.

Time frame: End of patient follow up.

Sponsors and collaborators

Lead sponsor

Boston Scientific Corporation

Industry

Registry information

Important dates

Study start: 2006
Primary completion: 2008
Study completion: 2008
First posted: Dec 31, 2007
Registry last updated: Feb 6, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed